Sometimes the search for quality biotech real estate along the Peninsula is simply a waiting game.
As tight venture capital checkbooks, the weak economy and risk-averse capital markets continue to squeeze cash-intensive biotech companies, deals on subleases for even freshly built space can be found.
It’s the proverbial win-win for companies — one sheds costs, the other gets top-drawer space for a fraction of the market price.
Sublease deals are nothing new, but the amount of ready-to-move-in, biotech-centric sublease space is strong for companies jumping into the lease market.
No comments:
Post a Comment